Literature DB >> 20110294

Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates.

Sébastien Coyne1, Patrice Courvalin1, Marc Galimand1.   

Abstract

Pseudomonas aeruginosa is a major human opportunistic pathogen, especially for patients in intensive care units or with cystic fibrosis. Multidrug resistance is a common feature of this species. In a previous study we detected the ant(4')-IIb gene in six multiresistant clinical isolates of P. aeruginosa, and determination of the environment of the gene led to characterization of Tn6061. This 26 586 bp element, a member of the Tn3 family of transposons, carried 10 genes conferring resistance to six drug classes. The ant(4')-IIb sequence was flanked by directly repeated copies of ISCR6 in all but one of the strains studied, consistent with ISCR6-mediated gene acquisition. Tn6061 was chromosomally located in six strains and plasmid-borne in the remaining isolate, suggesting horizontal acquisition. Duplication-insertion of IS6100, that ended Tn6061, was responsible for large chromosomal inversions. Acquisition of Tn6061 and chromosomal inversions are further examples of intricate mechanisms that contribute to the genome plasticity of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110294     DOI: 10.1099/mic.0.033639-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  13 in total

1.  Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis.

Authors:  C C Papagiannitsis; V Miriagou; S D Kotsakis; E Tzelepi; A C Vatopoulos; E Petinaki; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

2.  Evolution of AbGRI2-0, the Progenitor of the AbGRI2 Resistance Island in Global Clone 2 of Acinetobacter baumannii.

Authors:  Grace A Blackwell; Steven J Nigro; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

3.  PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosa.

Authors:  Guo-Bao Tian; Jennifer M Adams-Haduch; Tatiana Bogdanovich; Hong-Ning Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Analysis of IS1236-mediated gene amplification events in Acinetobacter baylyi ADP1.

Authors:  Laura E Cuff; Kathryn T Elliott; Sarah C Seaton; Maliha K Ishaq; Nicole S Laniohan; Anna C Karls; Ellen L Neidle
Journal:  J Bacteriol       Date:  2012-06-15       Impact factor: 3.490

Review 5.  Efflux-mediated antibiotic resistance in Acinetobacter spp.

Authors:  Sébastien Coyne; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

Review 6.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

Review 7.  The accessory genome of Pseudomonas aeruginosa.

Authors:  Vanderlene L Kung; Egon A Ozer; Alan R Hauser
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

8.  Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.

Authors:  Jun Sung Hong; Eun-Jeong Yoon; Hyukmin Lee; Seok Hoon Jeong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 9.  Bacterial genome instability.

Authors:  Elise Darmon; David R F Leach
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

10.  Unusual large-scale chromosomal rearrangements in Mycobacterium tuberculosis Beijing B0/W148 cluster isolates.

Authors:  Egor A Shitikov; Julia A Bespyatykh; Dmitry S Ischenko; Dmitry G Alexeev; Irina Y Karpova; Elena S Kostryukova; Yulia D Isaeva; Elena Y Nosova; Igor V Mokrousov; Anna A Vyazovaya; Olga V Narvskaya; Boris I Vishnevsky; Tatiana F Otten; Viacheslav Iu Zhuravlev; Valery Y Zhuravlev; Peter K Yablonsky; Elena N Ilina; Vadim M Govorun
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.